Antigen Potency and Maximal Efficacy Reveal a Mechanism of Efficient T Cell Activation
Overview
Physiology
Science
Authors
Affiliations
T cell activation, a critical event in adaptive immune responses, depends on productive interactions between T cell receptors (TCRs) and antigens presented as peptide-bound major histocompatibility complexes (pMHCs). Activated T cells lyse infected cells, secrete cytokines, and perform other effector functions with various efficiencies, which depend on the binding parameters of the TCR-pMHC complex. The mechanism through which binding parameters are translated to the efficiency of T cell activation, however, remains controversial. The "affinity model" suggests that the dissociation constant (KD) of the TCR-pMHC complex determines the response, whereas the "productive hit rate model" suggests that the off-rate (koff) is critical. Here, we used mathematical modeling to show that antigen potency, as determined by the EC50 (half-maximal effective concentration), which is used to support KD-based models, could not discriminate between the affinity and the productive hit rate models. Both models predicted a correlation between EC50 and KD, but only the productive hit rate model predicted a correlation between maximal efficacy (Emax), the maximal T cell response induced by pMHC, and koff. We confirmed the predictions made by the productive hit rate model in experiments with cytotoxic T cell clones and a panel of pMHC variants. Thus, we propose that the activity of an antigen is determined by both its potency (EC50) and maximal efficacy (Emax).
ATLAS-seq: a microfluidic single-cell TCR screen for antigen-reactive TCRs.
Luo S, Notaro A, Lin L Nat Commun. 2025; 16(1):216.
PMID: 39746936 PMC: 11696065. DOI: 10.1038/s41467-024-54675-3.
Engineering a tumor-selective prodrug T-cell engager bispecific antibody for safer immunotherapy.
McCue A, Demarest S, Froning K, Hickey M, Antonysamy S, Kuhlman B MAbs. 2024; 16(1):2373325.
PMID: 38962811 PMC: 11225918. DOI: 10.1080/19420862.2024.2373325.
Mechanical control of antigen detection and discrimination by T and B cell receptors.
Rogers J, Bajur A, Salaita K, Spillane K Biophys J. 2024; 123(15):2234-2255.
PMID: 38794795 PMC: 11331051. DOI: 10.1016/j.bpj.2024.05.020.
Tuning the potency and selectivity of ImmTAC molecules by affinity modulation.
Robertson I, Mulvaney R, Dieckmann N, Vantellini A, Canestraro M, Amicarella F Clin Exp Immunol. 2023; 215(2):105-119.
PMID: 37930865 PMC: 10847821. DOI: 10.1093/cei/uxad120.
A high throughput bispecific antibody discovery pipeline.
Segaliny A, Jayaraman J, Chen X, Chong J, Luxon R, Fung A Commun Biol. 2023; 6(1):380.
PMID: 37029216 PMC: 10082157. DOI: 10.1038/s42003-023-04746-w.